background
respiratori
virus
influenza
virus
initi
infect
upper
airway
manifest
sever
lower
respiratori
tract
infect
highrisk
patient
signific
morbid
mortal
syndrom
diagnosi
sever
multiplex
nucleic
acid
amplif
test
develop
clinic
surex
respiratori
pathogen
multiplex
kit
resp
simultan
detect
pathogen
directli
airway
secret
specimen
organ
identifi
influenza
viru
influenza
viru
influenza
viru
influenza
viru
b
adenoviru
boca
viru
rhinoviru
parainfluenza
viru
coronaviru
respiratori
syncyti
viru
human
metapneumoviru
mycoplasma
pneumonia
chlamydia
method
studi
provid
perform
evalu
data
assay
compar
pathogenspecif
pcr
oropharyng
swab
sampl
ten
pathogen
detect
assay
rhinoviru
adenoviru
influenza
viru
common
overal
agreement
resp
compar
test
resp
demonstr
agreement
posit
result
agreement
neg
result
conclus
resp
assay
demonstr
highli
concord
perform
compar
pathogenspecif
pcr
detect
respiratori
pathogen
oropharyng
swab
outpati
could
aid
diagnosi
respiratori
infect
varieti
clinic
scenario
k
e
w
r
acut
respiratori
infect
influenza
viru
multiplex
pcr
oropharyng
swab
respiratori
viru
cite
articl
zhang
cao
l
xu
z
et
al
evalu
multiplex
pcr
assay
detect
respiratori
virus
mycoplasma
pneumonia
oropharyng
swab
sampl
outpati
j
clin
lab
acut
respiratori
infect
ari
common
contribut
significantli
morbid
mortal
lead
caus
outpati
visit
hospit
age
group
especi
children
year
age
ari
children
outpati
caus
nine
common
respiratori
virus
includ
respiratori
syncyti
viru
rsv
influenza
viru
influenza
viru
b
rhinoviru
adenoviru
parainfluenza
viru
coronaviru
human
metapneumoviru
boca
viru
addit
atyp
pathogen
mycoplasma
pneumonia
also
major
caus
ari
children
symptom
caus
pathogen
larg
similar
thu
definit
diagnosi
requir
effect
laboratori
test
use
multiplex
assay
target
pathogen
earli
diagnosi
made
time
manner
consequenti
antimicrobi
antivir
therapi
may
thu
administr
promptli
appropri
importantli
earli
diagnosi
influenza
virus
contagi
benefici
earli
isol
patient
thu
reduc
spread
influenza
virus
routin
clinic
laboratori
test
respiratori
virus
larg
conduct
direct
fluorescentantibodi
assay
rapid
antigen
test
china
given
poor
sensit
complic
manual
oper
method
gradual
replac
nucleic
acid
amplif
test
naat
sensit
specif
howev
major
naat
kit
base
realtim
polymeras
chain
reaction
pcr
detect
one
two
pathogen
ari
within
singl
tube
thu
syndrom
test
clinic
econom
impact
syndrom
test
respiratori
pathogen
evalu
sever
studi
overal
implement
syndrom
test
decreas
time
diagnosi
decreas
healthcar
resourc
util
decreas
inpati
length
stay
time
isol
improv
antivir
use
influenza
virusposit
patient
surex
respiratori
pathogen
multiplex
kit
resp
syndrom
multiplex
molecular
test
simultan
detect
pathogen
singl
tube
aim
studi
evalu
applic
resp
detect
respiratori
pathogen
outpati
flulik
manifest
inclus
criteria
studi
follow
patient
admit
hospit
feb
aug
b
oropharyng
swab
collect
hospit
center
diseas
control
guangzhou
c
patient
follow
flulik
manifest
fever
b
cough
sore
throat
sampl
specimen
kept
transfer
laboratori
test
within
one
week
specimen
shaken
vigor
minut
phosphatebuff
salin
solut
centrifug
g
minut
supernat
aspir
rna
extract
supernat
use
qiaamp
viral
rna
extract
kit
qiagen
hilden
germani
accord
manufactur
instruct
store
nucleic
acid
subject
multiplex
amplif
specimen
use
surex
instruct
pathogen
detect
produc
distinct
fragment
size
pcr
amplif
result
fragment
analysi
use
determin
outcom
test
brief
peak
height
target
fragment
size
lower
lower
peak
signal
standard
target
pathogen
determin
neg
peak
height
target
fragment
size
higher
higher
peak
signal
standard
target
pathogen
determin
posit
peak
height
target
fragment
size
higher
lower
peak
signal
standard
target
pathogen
determin
uncertain
test
repeat
result
analyz
use
cohen
kappa
total
oropharyng
swab
enrol
hospit
cdc
guangzhou
sampl
collect
wide
rang
age
averag
age
tabl
specimen
male
chlamydia
six
ten
detect
pathogen
cohen
kappa
multiplex
pcrbase
naat
increasingli
use
syndrom
diagnosi
due
high
throughput
high
sensit
high
specif
costeffect
great
clinic
signific
resp
assay
base
multiplex
pcr
amplif
capillari
electrophoret
separ
pcr
amplicon
length
techniqu
use
pathogen
detect
subtyp
classif
pediatr
acut
lymphoblast
leukemia
compar
result
standard
size
marker
target
pathogen
pathogen
sampl
separ
identifi
expect
subtyp
virus
design
distinguish
assay
except
influenza
viru
influenza
viru
two
subtyp
popular
china
recent
therefor
patient
whose
specimen
posit
influenza
viru
neg
influenza
viru
probabl
infect
uncommon
influenza
viru
avian
influenza
viru
immedi
quarantin
confirm
note
f
g
u
r
e
neg
result
multipl
pcr
assay
resp
xaxi
repres
size
amplif
product
yaxi
repres
signal
strength
hurna
human
rna
hudna
human
dna
ic
intern
control
investig
need
evalu
perform
resp
pathogen
conclus
perform
resp
show
highdegre
agreement
pathogenspecif
pcr
oropharyng
swab
outpati
implement
resp
may
facilit
diagnosi
respiratori
infect
varieti
clinic
scenario
studi
support
grant
nation
scienc
